Will Fitbit boost its activity in healthcare?

Fitbit CEO James Park spoke about the expansion of the device in to the healthcare field recently, citing a lack of consumer engagement in healthcare as a problem he solve.

“We are learning that lack of consumer engagement is a critical missing element in many broad healthcare efforts such as population health and disease management,” Park said. “Since our devices and services are already engaging, Fitbit has incredible opportunity to serve as the consumer healthcare engagement engine. I could argue that, better than anyone else, we can help people engage with their health, engage with their family’s health, engage with their insurer and employer and engage with the healthcare system.”

Read more by following the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.